Mvo Portugal - Associacao Portuguesa De Verificacao De Medicamentos

What Mvo Portugal - Associacao Portuguesa De Verificacao De Medicamentos does

MVO Portugal (Associação Portuguesa de Verificação de Medicamentos) is a non-profit association serving as Portugal's designated National Medicines Verification Organization (NMVO). It operates the Portuguese national node of the pan-European medicines verification system established under EU Delegated Regulation 2016/161, which implements the Falsified Medicines Directive. The organization serves the entire Portuguese pharmaceutical supply chain — including Marketing Authorization Holders (MAHs), parallel import authorization (PIA) holders, wholesalers, and pharmacies — by enabling the authentication of prescription medicines through unique identifiers (2D barcodes) and tamper-evident packaging checks at the point of dispensing.

The core technology is the Portuguese verification platform, which connects to the European Medicines Verification Organisation (EMVO) hub and integrates with pharmacy dispensing systems through partnerships with AFP (Associação de Farmácias de Portugal) and ANF (Associação Nacional das Farmácias). The system allows end-to-end traceability of prescription medicines, ensuring that only legitimately manufactured and distributed products reach patients. Operational and regulatory oversight is coordinated with INFARMED, Portugal's national medicines and health products authority. No proprietary AI, machine learning, or advanced analytics capabilities are indicated in the input data.

MVO Portugal operates on a non-profit funding model. Revenue is generated through membership and participation fees paid by MAH and PIA holders, while pharmacies access the verification system through AFP and ANF portals under a freemium arrangement. No public pricing, revenue figures, or financial disclosures are available. The organization is headquartered in Miraflores, Algés, Portugal, with a disclosed headcount of 1–10 employees.

Name

Mvo Portugal - Associacao Portuguesa De Verificacao De Medicamentos

Legal name

MVO Portugal - Associação Portuguesa de Verificação de Medicamentos

Website

https://mvoportugal.pt

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

MVO Portugal is the designated National Medicines Verification Organization operating Portugal's node of the EU-mandated medicines verification system. It serves pharmaceutical manufacturers, wholesalers, and pharmacies by authenticating prescription medicines to prevent falsified products from reaching patients.

Ownership category

akta.pro rank

Product category

Pharmaceutical Compliance Services

akta.pro industry

PRIMARYHLAJADAI

Regulatory Affairs, Labeling & Advertising/Promotion Compliance

Healthcare & Life Sciences/Public Health, Government & Regulators/Medicines & Healthcare Product Regulators (Drugs/Biologics/Devices)

SECONDARYHLAJACAB

Healthcare Compliance & Enforcement Authorities

Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities

SECONDARYHLAGAKAG

Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

• Medicines verification system
• Pharmaceutical serialization
• Falsified medicines prevention
• National medicines verification
• Pharmaceutical supply chain

Headquarters

HQ city

Lisboa

HQ country

Portugal

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Infrastructure, Personnel, Operations, Others

Revenue model

1. Membership/Participation Fees: Marketing Authorization Holders (MAH) and Parallel Import Authorization (PIA) holders pay participation costs to connect to the national system. The exact fee structure is not publicly disclosed and is requested via email.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

MVO Portugal operates the Sistema Nacional de Verificação de Medicamentos (National Medicines Verification System), a national repository connected to the European Medicines Verification Organization (EMVO) hub. The system verifies the authenticity of medicine packages circulating in Portugal through unique identifiers encoded in DataMatrix barcodes (GS1 standard) and anti-tampering devices. The organization provides onboarding services for pharmaceutical manufacturers, distributors, pharmacies, and healthcare institutions to connect to the verification system as mandated by EU Regulation 2016/161.

Product overview

MVO Portugal operates the Sistema Nacional de Verificacao de Medicamentos (national medicines verification system), which is part of the pan-European medicines verification system managed by EMVO. The system consists of a national repository connected to the European hub, storing data about medicine packages circulating in Portugal. The core offering includes Dispositivos de Seguranca (safety features) comprising unique identifiers (DataMatrix barcodes with GTIN, serial number, batch, expiry, registration) and anti-tampering devices. MVO Portugal provides onboarding services for different stakeholder groups: Marketing Authorization Holders/PIA Holders who upload medicine data, Wholesalers who verify and decommission packages, Pharmacies who verify at dispensing, and Healthcare Institutions who verify when supplying to patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Sistema Nacional de Verificação de Medicamentos (National Medicines Verification System) Pan-European repository that stores information about medicine packages in circulation in Portugal, enabling verification of authenticity and decommissioning of unique identifiers. The system connects to the EMVO European hub for cross-border medicines verification across the European Economic Area.
• Dispositivos de Segurança (Safety Features) Safety features consisting of unique identifiers and anti-tampering devices placed on medicine packages. The unique identifier includes product code (GTIN), serial number, batch number, expiry date, and registration number encoded in a DataMatrix 2D barcode per GS1 standard. The anti-tampering device allows verification of whether a medicine pack has been opened or altered since leaving the manufacturer's facilities.

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

Partnerships

Five partnerships are on record, tiered core.

• European Medicines Verification Organization (EMVO)coreTechnology or IntegrationEMVO manages the European hub that connects all National Medicines Verification Organizations (NMVOs). MVO Portugal connects to this hub to enable pan-European medicines verification. Marketing authorization holders upload pack data to the hub, which then distributes to relevant national systems.
• National Medicines Verification Organizations (Other NMVOs)coreTechnology or IntegrationEach country in the EEA has its own National Medicines Verification Organization (NMVO) managing the national repository. MVO Portugal works with these organizations to ensure cross-border verification capabilities.
• Associação das Farmácias de Portugal (AFP)coreChannel Partner/ Reseller/ DistributorAFP represents Portuguese pharmacies and ensures the onboarding process of its members to the national medicines verification system. Provides access through the AFP pharmacy portal at no cost.
• Associação Nacional de Farmácias (ANF)coreChannel Partner/ Reseller/ DistributorANF represents Portuguese pharmacies and ensures the onboarding process of its members to the national medicines verification system. Provides access through the ANF pharmacy portal at no cost.
• INFARMED, I.P.coreOthersINFARMED is the Portuguese regulatory authority for medicines (Autoridade Nacional do Medicamento). They issued the direct medicine acquisition authorizations for healthcare institutions and prepared the Safety Features FAQ document referenced by MVO Portugal.

Scale indicators1 record

Recent moves5 records

Expansion highlights2 records

Market position

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/mvoportugal

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mvo Portugal - Associacao Portuguesa De Verificacao De Medicamentos